9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Estimated reading time: < 1 min

Condition: Cervical Cancer

Estimated Enrollment:

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: ,  ,  ,

Interventions: SS1(dsFv)-PE38 immunotoxin,

Phase:

Study Type: Interventional

Study Design: Masking: None (Open Label), Primary Purpose: Treatment, ,

Primary Completion Date:

Completion Date:

Last  Posted Date: April 30, 2015

Location: Warren Grant Magnuson Clinical Center – NCI Clinical Studies Support, Bethesda, Maryland, United States

Website Link: https://ClinicalTrials.gov/show/NCT00066651

Was this article helpful?
Dislike 0